Skip to main content
SpringerLink
Log in
Book cover

Prognosis in the Rheumatic Diseases pp 97–131Cite as

Crystal-associated arthropathies

  • Chapter

  • 121 Accesses

Abstract

Three types of crystal are associated with joint inflammation — namely, monosodium urate monohydrate (MSUM or urate); calcium pyrophosphate dihydrate (CPPD or pyrophosphate); and basic calcium phosphate (BCP or apatite; a combination of carbonate-substituted hyroxyapatite, octacalcium phosphate and tricalcium phosphate). Two of these crystal types, MSUM and CPPD, will consistently induce an acute arthritis when injected into a joint. The role of basic calcium phosphate in joint disease is less clear and its etiologic role in joint inflammation less well defined. The associated clinical patterns of these crystal-associated arthropathies are more clearly defined, however, and in this chapter these conditions will be considered separately as urate crystal arthropathy or gout, as pyrophosphate-deposition disease, and as apatite-associated arthritis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gutrnan, A. B. (1953). Primary and secondary gout. Ann. Intern. Med., 39, 1062–1076.

    Google Scholar 

  2. Brochner-Mortensen, K. (1937). Uric acid in blood and urine. Acta Med. Scand., 84 (suppl.), 1–269.

    Google Scholar 

  3. Fox, I. H. (1985). Adenosine triphosphate degradation in specific disease. J. Lab. Clin. Med., 106, 101–110.

    PubMed  CAS  Google Scholar 

  4. Emmerson, B. T. (1974). Effect of oral fructose on urate production. Ann. Rheum. Dis., 33, 276–280.

    Article  PubMed  CAS  Google Scholar 

  5. Sutton, J. R., Toews, C. J., Ward, G. R. and Fox, I. H. (1980). Purine metabolism during strenuous muscular exercise in man. Metabolism, 29, 254–260.

    Article  PubMed  CAS  Google Scholar 

  6. Emmerson, B. T. (1978). Abnormal urate excretion associated with renal and systemic disorders, drugs and toxins. In Kelley, W. N. and Weiner, I. M. (eds.) Uric Acid, pp. 287–315. (Berlin, Heidelberg, New York: Springer-Verlag).

    Chapter  Google Scholar 

  7. Gibson, T., Rodgers, A., Simmonds, H., Court-Brown, F., Todd, E. and Meilton, V. (1983). A controlled study of diet in patients with gout. Ann. Rheum. Dis., 42, 123–127.

    Article  PubMed  CAS  Google Scholar 

  8. Tofler, O. B. and Woodings, T. L. (1981). A 13-year follow-up of social drinkers. Med. J. Aust., 2, 479–481.

    PubMed  CAS  Google Scholar 

  9. Emmerson, B. T. (1973). Alteration of urate metabolism by weight reduction. Aust. NZ J. Med., 3, 410–412.

    Article  CAS  Google Scholar 

  10. Yamashita, S., Matsuzawa, Y., Tokunaga, S., Fujioka, S. and Tarui, S. (1986). Studies of the impaired metabolism of uric acid in obese subjects: marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int. J. Obesity, 10, 255–264.

    CAS  Google Scholar 

  11. Yano, K., Rhoads, G. G. and Kagan, A. (1977). Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J. Chronic Dis., 30, 171–184.

    Article  PubMed  CAS  Google Scholar 

  12. Spicer, J., McLeod, W. R., O’Brien, K. P. and Scott, P. J. (1979). Distributions and interrelations of coronary risk factors in a community sample of Auckland men. Aust. NZ J. Med., 9, 158–169.

    Article  CAS  Google Scholar 

  13. Goldbourt, U., Medalie, J. H., Herman, J. B. and Neufeld, H. N. (1980). Serum uric acid: correlation with biochemical anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J. Chronic Dis., 33, 435–443.

    Article  PubMed  CAS  Google Scholar 

  14. Gutman, A. B. and Yu, T-F. (1967). Renal function in gout. Am. J. Med., 23, 600–622.

    Article  Google Scholar 

  15. Rieselbach, R. E. and Steele, T. H. (1975). Intrinsic renal disease leading to abnormal urate excretion. Nephron, 14, 81–87.

    Article  PubMed  CAS  Google Scholar 

  16. Emmerson, B. T. and Row, P. G. (1975). An evaluation of the pathogenesis of the gouty kidney. Kidney Int., 8, 65–71.

    Article  PubMed  CAS  Google Scholar 

  17. Emmerson, B. T. (1973). Chronic lead nephropathy. Kidney Int., 4, 1–5.

    Article  PubMed  CAS  Google Scholar 

  18. Bartels, E. C. (1955). Gout — now amenable to control. Ann. Intern. Med., 42, 1–10.

    PubMed  CAS  Google Scholar 

  19. Smyth, C. J. and Frank, L. S. (1962). Treatment of gouty arthritis. Rheumatism, 18, 2–11.

    PubMed  CAS  Google Scholar 

  20. Actams, F. (transi.) (1886). The Genuine Works of Hippocrates. (New York: Wood).

    Google Scholar 

  21. Wallace, S. L., Robinson, H. J., Masi, A. T., Decker, J. L., McCarty, D. J. and Yu, T-F. (1977). Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum., 20, 895–900.

    Article  PubMed  CAS  Google Scholar 

  22. Rodnan, G. P. (1961). A gallery of gout. Arthritis Rheum., 4, 27–194.

    Article  PubMed  CAS  Google Scholar 

  23. Brochner-Mortensen, K. (1941). 100 gouty patients. Acta Mel Scand., 106, 81–107.

    Article  CAS  Google Scholar 

  24. Kuzell, W. C., Schaffarzick, R. W., Naugler, W. E., Koets, P., Mankle, E. A., Brown, B. and Champlin, B. (1955). Some observations on 520 gouty patients. J. Chronic Dis., 2, 645–669.

    Article  PubMed  CAS  Google Scholar 

  25. Rakic, M. T., Valkenburg, H. A., Davidson, R. T., Engels, J. P., Mikkelsen, W. M., Neel, J. V. and Duff, I. F. (1964). Observations on the natural history of hyperuricemia and gout. Am. J. Med., 37, 862–871.

    Article  PubMed  CAS  Google Scholar 

  26. Gutman, A. B. (1965). Treatment of primary gout: The present status. Arthritis Rheum., 8, 911–919.

    Article  PubMed  CAS  Google Scholar 

  27. Yu, T. F. and Gutman, A. B. (1961). Efficacy of colchicine prophylaxis in gout. Ann. Intern. Med., 55, 179–192.

    PubMed  CAS  Google Scholar 

  28. Hall, A. P., Barry, P. E., Dawber, T. R. and McNamara, P. M. (1967). Epidemiology of gout and hyperuricemia. Am. J. Med., 42, 27–37.

    Article  PubMed  CAS  Google Scholar 

  29. Grahame, R. and Scott, J. T. (1970). Clinical survey of 354 patients with gout. Ann. Rheum. Dis., 29, 461–468.

    Article  PubMed  CAS  Google Scholar 

  30. Gutman, A. B. (1971). Views on the pathogenesis and management of primary gout. J. Bone Joint Surg., 54A, 357–372.

    Google Scholar 

  31. Hall, A. P. (1965). Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension. Arthritis Rheum., 8, 846–852.

    Article  PubMed  CAS  Google Scholar 

  32. Feldman, E. B. and Wallace, S. L. (1964). Hypertriglyceridemia in gout. Circulation, 2, 508–513.

    Article  Google Scholar 

  33. Barlow, K. A. (1968). Hyperlipidemia in primary gout. Metabolism, 3, 289–299.

    Article  Google Scholar 

  34. Emmerson, B. T. (1979). Atherosclerosis and urate metabolism. Aust. NZ J. Med., 9, 451–454.

    Article  CAS  Google Scholar 

  35. Rondier, J., Truffert, J., Go, A. le, Cayla, J., Hila, A., de Gennes, J.-L. and Delbarre, F. (1977). Gout and hyperlipidemia — effect of overweight on the levels of circulating lipids. Ann. Clin. Res., 9, 239–245.

    PubMed  CAS  Google Scholar 

  36. Gibson, T. and Grahame, R. (1974). Gout and hyperlipidaemia. Ann. Rheum. Dis., 33, 298–303.

    Article  PubMed  CAS  Google Scholar 

  37. Gibson, T., Kilbourn, K., Horner, I. and Simmonds, H. A. (1979). Mechanism and treatment of hypertriglyceridaemia in gout. Ann. Rheum. Dis., 38, 31–35.

    Article  PubMed  CAS  Google Scholar 

  38. Fessel, J. (1980). High uric acid as an indicator of cardiovascular disease. Am. J. Med., 68, 401–404.

    Article  PubMed  CAS  Google Scholar 

  39. Darlington, L. G., Slack, J. and Scott, J. T. (1982). Family study of lipid and purine levels in gout patients. Ann. Rheum. Dis., 41, 253–256.

    Article  PubMed  CAS  Google Scholar 

  40. Abbott, R. D., Brand, F. N., Kannel, W. B. and Castelli, W. P. (1981). Gout and coronary heart disease: The Framingham study. J. Clin. Epidemiol, 3, 237–242.

    Google Scholar 

  41. Jiao, S., Kemeda, K., Matsuzawa, Y. and Tarui, S. (1986). Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan. Ann. Rheum. Dis., 45, 308–313.

    Article  PubMed  CAS  Google Scholar 

  42. Bishop, C., Rand, R. and Talbott, J. H. (1951). Effect of Benemid on uric acid metabolism in one normal and one gouty subject. J. Clin. Invest., 30, 889–905.

    Article  PubMed  CAS  Google Scholar 

  43. Kelley, W. N. (1975). Effects of drugs on uric acid in man. In Elliott, H. W., George, R. and Okun, R. (eds.) Annual Review of Pharmacology, 15, 327–350.

    Article  PubMed  CAS  Google Scholar 

  44. Rundles, R. W., Wyngaarden, J. B., Hitchings, G. H., Elion, G. B. and Silberman, H. R. (1963). Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricaemia and gout. Trans. Assoc. Am. Physicians, 76, 126.

    CAS  Google Scholar 

  45. Rundles, R. W., Metz, E. N. and Silberman, H. R. (1966). Allopurinol in the treatment of gout. Ann. Intern. Med., 64, 229–258.

    PubMed  CAS  Google Scholar 

  46. Hande, K. R., Noone, R. M. and Stone, W. J. (1984). Severe allopurinol toxicity. Am. J. Med., 76, 47–56.

    Article  PubMed  CAS  Google Scholar 

  47. Healy, L. A., Magid, G. J. and Decker, J. L. (1959). Uric acid retention due to hydrochlorothiazide. N. Engl. J. Med., 261, 1358.

    Article  Google Scholar 

  48. Labeeuw, M., Pozet, N., Hadj Aissa, A., Zech, P. Y., Sassard, J. and Laville, M. (1988). Uric acid renal handling: spontaneous changes and influence of a thiazide alone or associated with triamterene. Int. J. Clin. Pharmacol, 16, 79–83.

    Google Scholar 

  49. Emmerson, B. T. (1967). Regimen of indomethacin therapy in acute gouty arthritis. Br. Med. J., 2, 272–274.

    Article  PubMed  CAS  Google Scholar 

  50. Emmerson, B. T. (1983). Hyperuricaemia and Gout in Clinical Practice. (Syndey: Adis Health Science Press).

    Google Scholar 

  51. Arnold, M. H., Brooks, P. M., Savvas, P. and Ruff, S. (1988). Tophaceous gout of the axial skeleton. Aust. NZ J. Med., 18, 865–867.

    Article  CAS  Google Scholar 

  52. Lawry, II, G. V., Fan, P. T. and Bluestone, R. (1988). Polyarticular versus mono-articular gout: a prospective, comparative analysis of clinical features. Medicine, 67, 335–343.

    Article  PubMed  Google Scholar 

  53. Yu, T-F. (1977). Some unusual features of gouty arthritis in females. Semin. Arthritis Rheum., 6, 247–265.

    Article  PubMed  CAS  Google Scholar 

  54. Lally, E. V., Ho, G. and Kaplan, S. R. (1986). The clinical spectrum of gouty arthritis in women. Arch. Intern. Med., 146, 2221–2225.

    Article  PubMed  CAS  Google Scholar 

  55. Meyers, O. L. and Monteagudo, F. S. E. (1985). Gout in females: an analysis of 92 patients. Clin. Exp. Rheumatol., 3, 105–109.

    PubMed  CAS  Google Scholar 

  56. Meyers, O. L. and Monteagudo, F. S. E. (1986). A comparison of gout in men and women — a 10-year experience. S. Afr. Med. J., 70, 721–723.

    PubMed  CAS  Google Scholar 

  57. Borg, E. J. T. and Rasker, J. J. (1987). Gout in the elderly, a separate entity? Ann. Rheum. Dis., 46, 72–76.

    Article  PubMed  Google Scholar 

  58. Takala, J., Anttila, S., Gref, C. G. and Isomlaki, H. (1988). Diuretics and hyperuricemia in the elderly. Scand. J. Rheumatol., 17, 155–160.

    Article  PubMed  CAS  Google Scholar 

  59. MacFarlane, D. G. and Dieppe, P. A. (1985). Diuretic-induced gout in elderly women. Br. J. Rheumatol., 24, 155–157.

    Article  PubMed  CAS  Google Scholar 

  60. Campbell, S. M. (1988). Gout: how presentation, diagnosis, and treatment differ in the elderly. Geriatrics, 43, 71–77.

    PubMed  CAS  Google Scholar 

  61. Oren, B. G., Rich, M. and Belle, M. S. (1958). Chlorothiazide (diuril) as a hyperuricacidemic agent. J. Am. Med. Assoc, 168, 2128–2129.

    Article  PubMed  CAS  Google Scholar 

  62. Aronoff, A. (1960). Acute gouty arthritis precipitated by chlorothiazide. N. Engl. J. Med., 262, 767–769.

    Article  PubMed  CAS  Google Scholar 

  63. Bryant, J. M., Yu, T-F, Berger, L., Schvartz, N., Torosdag, S., Fletcher, L., Fertig, H., Schwartz, M. S. and Quan, R. B. F. (1962). Hyperuricemia induced by the administration of chlorthalidone and other sulfonamide diuretics. Am. J. Med., 33, 408–420.

    Article  PubMed  CAS  Google Scholar 

  64. Steele, T. H. and Oppenheimer, S. (1969). Factors affecting urate excretion following diuretic administration in man. Am. J. Med., 47, 564–574.

    Article  PubMed  CAS  Google Scholar 

  65. Weinman, E. J., Eknoyan, G. and Suki, W. N. (1975). The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. J. Clin. Invest., 55, 283–291.

    Article  PubMed  CAS  Google Scholar 

  66. Langford, H. G., Blaufox, M. D., Borhani, N. O., Curb, J. D., Molteni, A., Schneider, K. A. and Pressel, S. (1987). Is thiazide-produced uric acid elevation harmful? Ann. Intern. Med., 147, 645–649.

    Article  CAS  Google Scholar 

  67. Simkin, P. A., Campbell, P. M. and Larson, E. B. (1983). Gout in Heberden’s nodes. Arthritis Rheum., 26, 94–97.

    Article  PubMed  CAS  Google Scholar 

  68. Hollingworth, P., Scott, J. T. and Burry, H. C. (1983). Nonarticular gout: hyperuricemia and tophus formation without gouty arthritis. Arthritis Rheum., 26, 98–101.

    Article  PubMed  CAS  Google Scholar 

  69. Nugent, C. A. and Tyler, F. H. (1959). The renal excretion of uric acid in patients with gout and in non-gouty subjects. J. Clin. Invest., 38, 1890–1898.

    Article  PubMed  CAS  Google Scholar 

  70. Rieselbach, R. E., Sorensen, L. B., Shelp, W. D. and Steele, T. H. (1970). Diminished renal urate secretion per nephron as a basis for primary gout. Ann. Intern. Med., 73, 359–366.

    PubMed  CAS  Google Scholar 

  71. Puig, J. G., Anton, F. M., Jimenez, M. L. and Gutierrez, P. C. (1986). Renal handling of uric acid in gout: impaired tubular transport of urate not dependent on serum urate levels. Metabolism, 35, 1147–1153.

    Article  Google Scholar 

  72. McPhaul, J. J. (1968). Hyperuricemia and urate excretion in chronic renal disease. Metabolism, 17, 430–438.

    Article  PubMed  Google Scholar 

  73. Emmerson, B. T., Stride, P. J. and Williams, G. (1980). The clinical differentiation of primary gout from primary renal disease in patients with both gout and renal disease. In Rapado, A., Watts, R. W. E. and De Bruyn, C. H. M. M. (eds.) Purine Metabolism in Man — III A, pp. 9–13. (New York: Plenum Press).

    Chapter  Google Scholar 

  74. Sorensen, L. B. (1980). Gout secondary to chronic renal disease: studies on urate metabolism. Ann. Rheum. Dis., 39, 424–430.

    Article  PubMed  CAS  Google Scholar 

  75. Newcombe, D. S. (1973). Gouty arthritis and polycystic kidney disease. Ann. Intern. Med., 79, 605.

    PubMed  CAS  Google Scholar 

  76. Meijas, E., Navas, J., Lluberes, R. and Martinez-Maldonado, M. (1989). Hyperuricemia, gout and autosomal dominant polycystic kidney disease. Am. J. Med. Sci., 297, 145–148.

    Article  Google Scholar 

  77. Thompson, G. R., Weiss, J. J., Goldman, R. T. and Rigg, G. A. (1978). Familial occurrence of hyperuricemia, gout, and medullary cystic disease. Arch. Intern. Med., 138, 1614–1617.

    Article  PubMed  CAS  Google Scholar 

  78. Burke, J. R., Inglis, J. A., Craswell, P. W., Mitchell, K. R. and Emmerson, B. T. (1982). Juvenile nephronophthisis and medullary cystic disease — the same disease (report of a large family with medullary cystic disease associated with gout and epilepsy). Clin. Nephrol., 18, 1–8.

    PubMed  CAS  Google Scholar 

  79. Leumann, E. P. and Wegmann, W. (1983). Familial nephropathy with hyperuricemia and gout. Nephron, 34, 51–57.

    Article  PubMed  CAS  Google Scholar 

  80. Meyrier, A. (1976). Desensitization in a patient with chronic renal disease and severe allergy to allopurinol. Br. Med. J., 2, 458.

    Article  PubMed  CAS  Google Scholar 

  81. Fam, A. G., Paton, T. W. and Chalton, A. (1980). Reinstitution of allopurinol therapy after cutaneous reactions. Can. Med. Assoc. J., 123, 128–129.

    PubMed  CAS  Google Scholar 

  82. Emmerson, B. T., Hazelton, R. A. and Frazer, I. H. (1988). Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol. Arthritis Rheum., 31, 436–440.

    Article  PubMed  CAS  Google Scholar 

  83. Sydenham, T. A. (1788). A treatise of the gout. In The Works of Thomas Sydenham, Vol. 2. (London: Robinson, Otridge, Hayes and Newberry).

    Google Scholar 

  84. Scudamore, C. (1823). A Treatise on the Nature and Cure of Gout and Gravel. (London: Joseph Mallett).

    Google Scholar 

  85. Castelnau, N. F. I. (1843). Gouty kidney. Arch. Gen. Med. J., Comp. de Sci. Med., 3, 285.

    Google Scholar 

  86. Todd, R. B. (1857). Clinical Lectures on Certain Diseases of the Urinary Organs, and On Dropsies. (London: Churchill).

    Google Scholar 

  87. Garrod, A. B. (1876). A Treatise on Gout and Rheumatic Gout, 3rd edn. (London: Longmans, Green and Co.).

    Google Scholar 

  88. Schnitker, M. A. and Richter, A. B. (1936). Nephritis in gout. Am. J. Med. Sci., 192, 241–251.

    Article  Google Scholar 

  89. Brown, J. B. and Mallory, G. K. (1950). Renal changes in gout. N. Engl. J. Med., 243, 325–329.

    Article  PubMed  CAS  Google Scholar 

  90. Talbott, J. H. and Terplan, K. L. (1960). The kidney in gout. Medicine (Baltimore), 39, 405–462.

    CAS  Google Scholar 

  91. Barry, K. G., Hunter, R. H., Davis, T. E. and Crosby, W. H. (1963). Acute uric acid nephropathy. Arch. Intern. Med., 3, 452–459.

    Article  Google Scholar 

  92. Simmonds, H. A., Cameron, J. S., Morris, G. S. and Davies, P. M. (1986). Allopurinol in renal failure and the tumour lysis syndrome. Clin. Chim. Acta, 160, 189–195.

    Article  PubMed  CAS  Google Scholar 

  93. Batch, J. A., Riek, R. P., Gordon, R. B., Burke, J. R. and Emmerson, B. T. (1984). Renal failure in infancy due to urate over-production. Aust. NZ J. Med., 14, 852–854.

    Article  CAS  Google Scholar 

  94. Kelton, J., Kelley, W. N. and Holmes, E. W. (1978). A rapid method for the diagnosis of acute uric acid nephropathy. Arch. Intern. Med., 138, 612–615.

    Article  PubMed  CAS  Google Scholar 

  95. Seegmiller, J. E. and Frazier, P. D. (1966). Biochemical considerations of the renal damage of gout. Ann. Rheum. Dis., 25, 668–672.

    PubMed  CAS  Google Scholar 

  96. Farebrother, D. A., Pincott, J. R., Simmonds, H. A., Warren, D. J., Dillon, M. J. and Cameron, J. S. (1981). Uric acid crystal induced nephropathy: evidence for a specific renal lesion in a gouty family. J. Pathol., 135, 159–168.

    Article  PubMed  CAS  Google Scholar 

  97. Beck, L. H. (1986). Requiem for gouty nephropathy. Kidney Int., 30, 280–287.

    Article  PubMed  CAS  Google Scholar 

  98. Gibson, T., Rodgers, V., Potter, C. and Simmonds, H. A. (1982). Allopurinol treatment and its effect on renal function in gout: a controlled study. Ann. Rheum. Dis., 41, 59–65.

    Article  PubMed  CAS  Google Scholar 

  99. Fessel, W. J. (1979). Renal outcomes of gout and hyperuricemia. Am. J. Med., 67, 74–82.

    Article  PubMed  CAS  Google Scholar 

  100. Berger, L. and Yu, T-F. (1975). Renal function in gout. Am. J. Med., 59, 605–613.

    Article  PubMed  CAS  Google Scholar 

  101. Yu, T-F. and Berger, L. (1982). Impaired renal function in gout. Am. J. Med., 72, 95–100.

    Article  PubMed  CAS  Google Scholar 

  102. Emmerson, B. T. (1988). Hyperuricemia, gout and the kidney. In Schrier, R. W. and Gottschalk, C. W. (eds.) Diseases of the Kidney, 4th edn. pp. 2481–2510. (Boston/ Toronto: Little, Brown & Co.).

    Google Scholar 

  103. Emmerson, B. T. (1989). Gout and renal disease. In Massry, S. G. and Glassock, R. J. (eds.) Textbook of Nephrology, 2nd edn. pp. 756–760. (Baltimore: Williams & Wilkins).

    Google Scholar 

  104. Campion, E. W., Glynn, R. J. and DeLabry, L. O. (1987). Asymptomatic hyperuricemia. Am. J. Med., 82, 421–426.

    Article  PubMed  CAS  Google Scholar 

  105. Currie, W. J. C. and Turner, P. (1979). The frequency of renal stones within Great Britain in a gouty and non-gouty population. Br. J. Urol., 51, 337–341.

    Article  PubMed  CAS  Google Scholar 

  106. Yu, T-F. and Talbott, J. H. (1980). Changing trends of mortality in gout. Semin. Arthritis Rheum., 10, 1–9.

    Article  PubMed  CAS  Google Scholar 

  107. Darlington, L. G., Slack, J. and Scott, J. T. (1983). Vascular mortality in patients with gout and in their families. Ann. Rheum. Dis., 42, 270–273.

    Article  PubMed  CAS  Google Scholar 

  108. Ungerleider, H. E. (1954). The internist and life insurance. Ann. Intern. Med., 41, 124–130.

    PubMed  CAS  Google Scholar 

  109. Talbott, J. H. and Lilienfeld, A. (1959). Longevity in gout. Geriatrics, 14, 409–420.

    Google Scholar 

  110. Gutman, A. B. (1972). Views on the pathogenesis and management of primary gout. J. Bone Joint Surg., 54A, 357–372.

    Google Scholar 

  111. Talbott, J. H. and Yu, T-F. (1976). Gout and Uric Acid Metabolism. (New York: Stratton Intercontinental Medical Book Corp.).

    Google Scholar 

  112. Zitnan, D. and Sitaj, S. (1963). Chondrocalcinosis articularis, section I, clinical and radiological study. Ann. Rheum. Dis., 22, 142–152.

    Article  PubMed  CAS  Google Scholar 

  113. McCarty, D. J., Kohn, N. N. and Faires, J. S. (1962). The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: the “pseudo-gout syndrome”. Ann. Intern. Med., 56, 71–737.

    Google Scholar 

  114. Moskowitz, R. W. and Katz, D. (1967). Chondrocalcinosis and chrondrocaly-synovitis (pseudogout syndrome). Am. J. Med., 43, 332–334.

    Article  Google Scholar 

  115. McCarty, D. J. (1963). Crystal-induced inflammation; syndromes of gout and pseudogout. Geriatrics, 18, 467–478.

    PubMed  Google Scholar 

  116. Doherty, M. and Dieppe, P. A. (1981). Acute pseudogout: “crystal shedding” or acute crystallization? Arthritis Rheum., 24, 954–957.

    Article  PubMed  CAS  Google Scholar 

  117. Pritzker, K. P. H., Cheng, P-T. and Renlund, R. C. (1988). Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis. J. Rheumatol, 15, 828–835.

    PubMed  CAS  Google Scholar 

  118. Rodriguez-Valverde, V., Zuniga, M., Casanueva, B., Sanchez, S. and Merino, J. (1988). Hereditary articular chondrocalcinosis. Am. J. Med., 84, 101–106.

    Article  PubMed  CAS  Google Scholar 

  119. Riestra, J. L., Sanchez, A., Rodriguez-Valverde, V., Alonso, J. L., de la Hera, M. and Merino, J. (1988). Radiographic features of hereditary articular chondrocalcinosis. A comparative study with the sporadic type. Clin. Exp. Rheumatol., 6, 369–372.

    PubMed  CAS  Google Scholar 

  120. Lust, G., Faure, G., Netter, P., Gaucher, A. and Seegmiller, J. E. (1981). Evidence of a generalized metabolic defect in patients with hereditary chondrocalcinosis. Arthritis Rheum., 24, 1517–1527.

    Article  PubMed  CAS  Google Scholar 

  121. Pritchard, M. H. and Jessop, J. D. (1977). Chondrocalcinosis in primary hyper-parathyroidism. Ann. Rheum. Dis., 36, 146–151.

    Article  PubMed  CAS  Google Scholar 

  122. Bilezikian, J. P., Connor, T. B., Aptekar, R., Freijanes, J., Aurbach, G. D., Pachas, W. N., Wells, S. A. and Decker, J. L. (1973). Pseudogout after parathyroidectomy. Lancet, 1, 7801–7802.

    Google Scholar 

  123. Doherty, M. and Dieppe, P. (1986). Crystal deposition disease in the elderly. Clin. Rheumatol., 12, 97–116.

    CAS  Google Scholar 

  124. Milazzo, S. C., Ahern, M. J., Cleland, L. G. and Henderson, D. R. (1981). Calcium pyrophosphate dihydrate deposition disease and familial hypomagnesemia. J. Rheumatol, 8, 767–771.

    PubMed  CAS  Google Scholar 

  125. Hollingworth, P., Williams, P. L. and Scott, J. T. (1982). Frequency of chondrocalcinosis of the knees in asymptomatic hyperuricaemia and rheumatoid arthritis: a controlled study. Ann. Rheum. Dis., 41, 344–364.

    Article  PubMed  CAS  Google Scholar 

  126. Alexander, G. M., Dieppe, P. A., Doherty, M and Scott, D. G. I. (1982). Pyrophosphate arthropathy: a study of metabolic associations and laboratory data. Ann. Rheum. Dis., 41, 377–381.

    Article  PubMed  CAS  Google Scholar 

  127. Settas, L., Doherty, M. and Dieppe, P. (1982). Localized chondrocalcinosis in unstable joints. Br. Med. J., 285, 175–176.

    Article  CAS  Google Scholar 

  128. Jacobelli, S., McCarty, D. J., Silcox, D. C. and Mall, J. C. (1973). Calcium pyrophosphate dihydrate crystal deposition in neuropathic joints. Ann. Intern. Med., 79, 340–347.

    PubMed  CAS  Google Scholar 

  129. Ellman, M. H., Brown, N. L. and Katzenberg, C. A. (1979). Acute pseudogout in chronic renal failure. Arch. Intern. Med., 139, 795–796.

    Article  PubMed  CAS  Google Scholar 

  130. McCarty, D. J., Hogan, J. M., Gatter, R. A. and Grossman, M. (1966). Studies of pathological calcifications in human cartilage. Bone Joint Surg. (Am)., 48, 309–325.

    Google Scholar 

  131. Mitrovic, D. R., Stankovic, A., Iriarte-Borda, O., Uzan, M., Quintero, M., Miravet, L. and Kuntz, D. (1988). The prevalence of chondrocalcinosis in the human knee. J. Rheumatol, 15, 633–641.

    PubMed  CAS  Google Scholar 

  132. Dieppe, P. A., Alexander, G. J. M., Jones, H. E., Doherty, M., Scott, D. G. I., Manhire, A. and Watt, I. (1982). Pyrophosphate arthropathy: a clinical and radiological study of 105 cases. Ann. Rheum. Dis., 41, 371–376.

    Article  PubMed  CAS  Google Scholar 

  133. Ellman, M. H., Brown, N. L. and Levin, B. (1981). Narrowing of knee joint space in patients with pseudogout. Ann. Rheum. Dis., 40, 34–36.

    Article  PubMed  CAS  Google Scholar 

  134. Resnick, C. S. and Resnick, D. (1983). Crystal deposition disease. Semin. Arthritis Rheum., 12, 390–403.

    Article  PubMed  Google Scholar 

  135. Gordon, T. P., Smith, M., Ebert, B., McCredie, M. and Brooks, P. M. (1984). Articular chondrocalcinosis in a hospital population: an Australian experience. Aust. N.Z. J. Med., 14, 655–659.

    Article  PubMed  CAS  Google Scholar 

  136. Storey, G. O. and Huskisson, E. C. (1977). Unusual presentations of pyrophosphate arthropathy. Br. Med. J., 2, 21–22.

    Article  PubMed  CAS  Google Scholar 

  137. Gerster, J-C., Lagier, R. and Boivin, G. (1982). Olecranon bursitis related to calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum., 25, 989–995.

    Article  PubMed  CAS  Google Scholar 

  138. Berghausen, E. J., Balough, K., Landis, W. J., Lee, D. D. and Wright, A. M. (1987). Cervical myelopathy attributable to pseudogout. Case report with radiologic, histologic and crystallographic observations. Clin. Orthop., 214, 217–221.

    PubMed  Google Scholar 

  139. Hutton, C. W., Doherty, M. and Dieppe, P. A. (1987). Acute pseudogout of the temporomandibular joint: a report of three cases and review of the literature. Br. J. Rheumatol, 26, 51–52.

    Article  PubMed  CAS  Google Scholar 

  140. Webb, J., Deodhar, S. and Lee, P. (1974). Chronic destructive polyarthritis due to pyrophosphate crystal arthritis. Med. J. Aust., 2, 206–209.

    PubMed  CAS  Google Scholar 

  141. Bong, D. and Bennett, R. (1981). Pseudogout mimicking systemic disease. J. Am. Med. Assoc, 246, 1438–1440.

    Article  CAS  Google Scholar 

  142. Spilberg, I., McLain, D., Simchowitz, L. and Berney, S. (1980). Colchicine and pseudogout. Arthritis Rheum., 23, 1062–1063.

    Article  PubMed  CAS  Google Scholar 

  143. Alvarellos, A. and Spilberg, I. (1986). Colchicine prophylaxis in pseudogout. J. Rheumatol., 13, 804–805.

    PubMed  CAS  Google Scholar 

  144. Bjelle, A., Edvinsson, U. and Hagstam, A. (1982). Pyrophosphate arthropathy in two Swedish families. Arthritis Rheum., 25, 66–74.

    Article  PubMed  CAS  Google Scholar 

  145. Dieppe, P. A., Crocker, P., Huskisson, E. C. and Willoughby, D. A. (1976). Apatite deposition diseases: A new arthropathy. Lancet, 1, 266–268.

    Article  PubMed  CAS  Google Scholar 

  146. Schumacher, H. R., Somlyo, A. P., Tse, R. L. and Maurer, K. (1977). Arthritis associated with apatite crystals. Ann. Intern. Med., 87, 411–416.

    PubMed  CAS  Google Scholar 

  147. Thompson, G. R., Ming Ting, Y., Riggs, G. A., Fenn, M. Ellen, and Denning, R. M. (1968). Calcific tendinitis and soft-tissue calcification resembling gout. J. Am. Med. Assoc, 203, 122–130.

    Article  Google Scholar 

  148. Dieppe, P. A., Crocker, P. R., Corke, C. F., Doyle, D. V., Huskisson, E. C. and Willoughby, D. A. (1979). Synovial fluid crystals. Q. J. Med., 48, 533–553.

    PubMed  CAS  Google Scholar 

  149. Halverson, P. B. and McCarty, D. J. (1986). Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann. Rheum. Dis., 45, 603–605.

    Article  PubMed  CAS  Google Scholar 

  150. Schumacher, H. R., Miller, J. L., Ludivico, C. and Jessar, R. A. (1981). Erosive arthritis associated with apatite crystal deposition. Arthritis Rheum., 24, 31–37.

    Article  PubMed  CAS  Google Scholar 

  151. Gibiliso, P. A., Schumacher, H. R., Hollander,J. L. and Soper, K. A. (1985). Synovial fluid crystals in osteoarthritis. Arthritis Rheum., 28, 511–515.

    Article  Google Scholar 

  152. Dieppe, P. A., Doherty, M., MacFarlane, D. G., Hutton, C. W., Bradfield, J. W. and Watt, I. (1984). Apatite associated destructive arthritis. Br. J. Rheumatol, 23, 84–91.

    Article  PubMed  CAS  Google Scholar 

  153. McCarty, D. J., Halverson, P. B., Carrera, G. F., Brewer, B. J. and Kozin, F. (1981). “Milwaukee shoulder” — association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. Arthritis Rheum., 24, 464–473

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. T. Emmerson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Western Ontario, London, Ontario, Canada

    Nicholas Bellamy MD, MSc, FRCP(Glas), FRCP(Edin), FRCP(C), FACP (Associate Professor of Medicine, Epidemiology and Biostatistics, Director) (Associate Professor of Medicine, Epidemiology and Biostatistics, Director)

  2. Division of Rheumatology, Victoria Hospital, London, Ontario, Canada

    Nicholas Bellamy MD, MSc, FRCP(Glas), FRCP(Edin), FRCP(C), FACP (Associate Professor of Medicine, Epidemiology and Biostatistics, Director) (Associate Professor of Medicine, Epidemiology and Biostatistics, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Emmerson, B.T. (1991). Crystal-associated arthropathies. In: Bellamy, N. (eds) Prognosis in the Rheumatic Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3896-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3896-3_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5735-6

  • Online ISBN: 978-94-011-3896-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation